Nerve News and Research

RSS

Cefaly medical device receives FDA approval for migraine prevention

CEFALY Technology announced today that its received U.S. Food and Drug Administration approval of the Cefaly medical device for the preventative treatment for migraine headaches. Cefaly is the first transcutaneous electrical nerve stimulation (TENS) device specifically authorized for use prior to the onset of pain. It is expected to be available in the U.S. in early April.

13 Mar 2014

Researchers discover two new gene regions connected to bipolar disorder

First on top of the world and then in the depths of despair - this is what the extreme mood changes for people with bipolar disorder are like. Under the direction of scientists from Bonn, Mannheim and Basel, an international collaboration of researchers discovered two new gene regions that are connected to the prevalent disease. In addition, they were able to confirm three additional suspect genes.

11 Mar 2014

Nerve growth factor may be dynamic marker of OAB pathophysiology

Urine levels of nerve growth factor fluctuate in line with changes in bladder pathophysiology, a 5-year study of people with overactive bladder has found.

10 Mar 2014

Men who have poorer cardiovascular fitness at 18 years more often suffer from dementia before 60

Men who at the age of 18 years have poorer cardiovascular fitness and/or a lower IQ more often suffer from dementia before the age of 60. This is shown in a recent study encompassing more than one million Swedish men.

10 Mar 2014

Mainstay Medical initiates clinical trial to investigate ReActiv8 as treatment for adults with CLBP

Mainstay Medical today announced that it has secured approval from Ethics Committees in Australia to start a clinical trial of ReActiv8, its innovative implantable neurostimulation device for the treatment of people with Chronic Low Back Pain (CLBP). Recruitment of subjects for the trial has commenced at three clinical sites in Australia.

10 Mar 2014

FDA-approved anti-psychotic drugs possess tumor-killing activity against glioblastoma

Researchers at the University of California, San Diego School of Medicine have discovered that FDA-approved anti-psychotic drugs possess tumor-killing activity against the most aggressive form of primary brain cancer, glioblastoma. The finding was published in this week's online edition of Oncotarget.

8 Mar 2014

Longtime allies team up to create Penn Medicine/CHOP Friedreich's Ataxia Center of Excellence

Three longtime allies have joined forces to create the new Penn Medicine/CHOP Friedreich's Ataxia Center of Excellence.

7 Mar 2014

National clinical trial to test new avenue for tinnitus treatment

UT Southwestern Medical Center will take part in a national clinical trial to test a device that could provide relief for people suffering from tinnitus, a persistent buzzing or ringing sound in the ears. The device uses nervous system stimuli to rewire parts of the brain, in hopes of significantly reducing or removing tinnitus.

7 Mar 2014

APS annual meeting to be held in Tampa from April 30 to May 3, 2014

The 33rd Annual Scientific Meeting of the American Pain Society (APS) will convene April 30 through May 3 at the Tampa Convention Center.

7 Mar 2014

Research explores new diagnostic strategies to detect glaucoma

Research exploring several new diagnostic strategies to find the earliest changes in the eye to detect glaucoma is underway at the University of Alabama at Birmingham School of Optometry. One optometrist says awareness of this eye disorder is just as important as continuing to study it.

7 Mar 2014

New findings shed light on how gene mutation causes motor neurone disease

Researchers have discovered a mechanism that may explain how a recently discovered mutation causes two devastating neurological diseases.

6 Mar 2014

Expression of MYC gene important for neurogenesis in the spinal cord

Research from Karolinska Institutet in Sweden suggests that the expression of the so called MYC gene is important and necessary for neurogenesis in the spinal cord. The findings are being published in the journal EMBO Reports.

6 Mar 2014

Minimally invasive surgery outcomes show favorable results in low back pain patients

Beaumont research findings published in the February online issue of Spine shows that patients who have a low back surgery called minimally invasive transforaminal lumbar interbody fusion, end up better off in many ways than patients who have more invasive surgery to alleviate debilitating pain.

5 Mar 2014

Plant pigment could prevent damage to nerves linked with childhood form of SMA

The research team have found that a plant pigment called quercetin - present in some fruits, vegetables, herbs and grains - could help to prevent damage to the nerves associated with the childhood form of motor neurone disease, spinal muscular atrophy (SMA).

5 Mar 2014

Researchers unravel function of proteins involved in cell metabolism

UCPs or uncoupling proteins are present in mitochondria, the powerhouse of each cell in the body. The functions of most of the five known UCPs remain mysterious (UCP2-UCP5), whereby only the distinct function for UCP1 has thus far been discovered.

5 Mar 2014

Georgia Regents Medical Center explores new treatment for Parkinson's disease-related constipation

Georgia Regents Medical Center is among about a dozen centers nationally exploring the potential of a new drug that may offer relief to people with Parkinson's who have failed standard approaches to treating constipation.

5 Mar 2014

Study: Thickness of brain's cortex linked with person's change in IQ

Rate of change in the thickness of the brain's cortex is an important factor associated with a person's change in IQ, according to a collaborative study by scientists in five countries including researchers at the Montreal Neurological Institute and Hospital - The Neuro, at McGill University and the McGill University Health Centre.

5 Mar 2014

Nerve News and Research

Cefaly medical device receives FDA approval for migraine prevention

Researchers discover two new gene regions connected to bipolar disorder

Nerve growth factor may be dynamic marker of OAB pathophysiology

Men who have poorer cardiovascular fitness at 18 years more often suffer from dementia before 60

Mainstay Medical initiates clinical trial to investigate ReActiv8 as treatment for adults with CLBP

FDA-approved anti-psychotic drugs possess tumor-killing activity against glioblastoma

Longtime allies team up to create Penn Medicine/CHOP Friedreich's Ataxia Center of Excellence

National clinical trial to test new avenue for tinnitus treatment

APS annual meeting to be held in Tampa from April 30 to May 3, 2014

Research explores new diagnostic strategies to detect glaucoma

New findings shed light on how gene mutation causes motor neurone disease

Expression of MYC gene important for neurogenesis in the spinal cord

Minimally invasive surgery outcomes show favorable results in low back pain patients

Plant pigment could prevent damage to nerves linked with childhood form of SMA

Researchers unravel function of proteins involved in cell metabolism

Georgia Regents Medical Center explores new treatment for Parkinson's disease-related constipation

Study: Thickness of brain's cortex linked with person's change in IQ

Nerve cells from horse stem cells may pave way for cell therapies, say researchers

NC-stat DPNCheck is a fast, accurate point-of-care test for diabetic peripheral neuropathy

Diamond-tipped drills reduce noise level, offer health and environmental benefits

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News